Previous studies have suggested that adipose‐derived sFlt155 and macrophage‐derived WNT5A56 promote alternate splicing of the VEGF‐A gene into VEGF‐165b,57 which inhibits angiogenesis and collateral vessel formation in PAD. This evidence concerns the gene VEGFA and peripheral arterial disease.